Biopharma PEG Scientific Inc.

Antibody-Drug Conjugates (ADC) is a type of anticancer drug that links a drug to cancer-targeting antibodies. The antibody detects tumor-specific proteins expressed on cancer cells and directs the cytotoxic anticancer drug towards the cancer cell.

A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time of patients with refractory...

The coronavirus pandemic has made vaccines from Pfizer/BioNTech and Moderna and the mRNA technology that they use into household names.

Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing...

The FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech & the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals.

Unlike common diseases such as colds and coughs, cancer is a more significant disease with a high mortality rate. Globally, cancer causes the second largest number of deaths after cardiovascular disease.

Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight.

The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) is used to protect against COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The FDA has granted accelerated approval to Sacituzumab Govitecan on April 13, 2021 for use in adult patients with locally advanced or metastatic urothelial cancer who have previously received platinum-containing chemotherapy and either a programmed...

Click chemistry has come into its own in a wide range of life science applications and opens up opportunities that lie between chemistry, biology and material science.